HQY

HQY

USD

HealthEquity Inc. Common Stock

$103.250-1.260 (-1.206%)

Precio en Tiempo Real

Healthcare
Health Information Services
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$104.510

Máximo

$104.560

Mínimo

$103.250

Volumen

0.85M

Fundamentos de la Empresa

Capitalización de Mercado

8.9B

Industria

Health Information Services

País

United States

Estadísticas de Negociación

Volumen Promedio

1.26M

Bolsa

NMS

Moneda

USD

Rango de 52 Semanas

Mínimo $65.01Actual $103.250Máximo $116.65

Noticias Relacionadas

Analyst Upgrades

Barrington Research Maintains Outperform on HealthEquity, Raises Price Target to $125

Barrington Research analyst Alexander Paris maintains HealthEquity with a Outperform and raises the price target from $112 to $125.

Ver más
Barrington Research Maintains Outperform on HealthEquity, Raises Price Target to $125
Analyst Upgrades

Deutsche Bank Maintains Buy on HealthEquity, Raises Price Target to $115

Deutsche Bank analyst George Hill maintains HealthEquity with a Buy and raises the price target from $98 to $115.

Ver más
Deutsche Bank Maintains Buy on HealthEquity, Raises Price Target to $115
Analyst Upgrades

Goldman Sachs Maintains Neutral on HealthEquity, Raises Price Target to $104

Goldman Sachs analyst David Roman maintains HealthEquity with a Neutral and raises the price target from $94 to $104.

Ver más
Goldman Sachs Maintains Neutral on HealthEquity, Raises Price Target to $104
Analyst Upgrades

RBC Capital Maintains Outperform on HealthEquity, Raises Price Target to $117

RBC Capital analyst Daniel Perlin maintains HealthEquity with a Outperform and raises the price target from $112 to $117.

Ver más
RBC Capital Maintains Outperform on HealthEquity, Raises Price Target to $117
Analyst Upgrades

B of A Securities Maintains Buy on HealthEquity, Raises Price Target to $125

B of A Securities analyst Allen Lutz maintains HealthEquity with a Buy and raises the price target from $110 to $125.

Ver más
B of A Securities Maintains Buy on HealthEquity, Raises Price Target to $125
Analyst Upgrades

JMP Securities Maintains Market Outperform on HealthEquity, Raises Price Target to $117

JMP Securities analyst Constantine Davides maintains HealthEquity with a Market Outperform and raises the price target from $110 to $117.

GlobeNewswire

HealthEquity Reports First Quarter Ended April 30, 2025 Financial Results

Highlights of the first quarter include: Revenue of $330.8 million, an increase of 15% compared to $287.6 million in Q1 FY25.Net income of $53.9 million, an increase of 87% compared to $28.8 million in Q1 FY25, with

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.